AI Summary
This article focuses on building predictive models for aggregation kinetics based on molecular dynamics simulations of an antibody fragment. The research likely delves into understanding the factors affecting the aggregation process of antibodies, which is crucial for the development of stable and effective therapeutic proteins. By studying the molecular dynamics of the antibody fragment, the researchers aim to predict its aggregation behavior, potentially leading to insights that can inform drug design and manufacturing processes. The study's findings could have significant implications for the pharmaceutical industry and the field of therapeutic protein development.
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00859